Findings based on survey encompassing six clinical contexts involving heightened risk for firearm injury
No impact on receipt of opioid or nonopioid pain treatment seen among patients with chronic noncancer pain
Strongest demographic predictor for discharge initiation of medications for alcohol use disorder was younger age
Improvement in global cognition seen for patients with Alzheimer disease/MCI, but no effects seen for healthy individuals, other patient populations
Increased rates seen for suicide attempts, suicide mortality, suicide-unrelated mortality, all-cause mortality versus nontransgender individuals
Increase seen in age-adjusted rate of drug overdose deaths involving xylazine from 0.03 to 1.06 per 100,000 standard population
$500,000 increase in penalty linked to a 2.9 percentage point increase in compliance
Over the same time period, age of gender dysphoria diagnosis dropped
Severity of grief tied to greater increases in blood pressure
Adjusted prevalence of nicotine dependence was lower for those aged 18 to 25, 26 to 34, 35 to 49 versus those aged 50 and older